Skip to main content
Article thumbnail
Location of Repository

CD1d-dependent Activation of NKT Cells Aggravates Atherosclerosis

By Emmanuel Tupin, Antonino Nicoletti, Rima Elhage, Mats Rudling, Hans-Gustaf Ljunggren, Göran K. Hansson and Gabrielle Paulsson Berne

Abstract

Adaptive and innate immunity have been implicated in the pathogenesis of atherosclerosis. Given their abundance in the lesion, lipids might be targets of the atherosclerosis-associated immune response. Natural killer T (NKT) cells can recognize lipid antigens presented by CD1 molecules. We have explored the role of CD1d-restricted NKT cells in atherosclerosis by using apolipoprotein E–deficient (apoE−/−) mice, a hypercholesterolemic mouse model that develops atherosclerosis. ApoE−/− mice crossed with CD1d−/− (CD1d−/−apoE−/−) mice exhibited a 25% decrease in lesion size compared with apoE−/− mice. Administration of α-galactosylceramide, a synthetic glycolipid that activates NKT cells via CD1d, induced a 50% increase in lesion size in apoE−/− mice, whereas it did not affect lesion size in apoE−/−CD1d−/− mice. Treatment was accompanied by an early burst of cytokines (IFNγ, MCP-1, TNFα, IL-2, IL-4, IL-5, and IL-6) followed by sustained increases in IFNγ and IL-4 transcripts in the spleen and aorta. Early activation of both T and B cells was followed by recruitment of T and NKT cells to the aorta and activation of inflammatory genes. These results show that activation of CD1d-restricted NKT cells exacerbates atherosclerosis

Topics: Brief Definitive Report
Publisher: The Rockefeller University Press
OAI identifier: oai:pubmedcentral.nih.gov:2211791
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2003). Activation of natural killer T cells by alpha-galac-
    2. (2003). CD1-restricted antigen presentation: an oily matter.
    3. (1992). Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells.
    4. (2001). Immune mechanisms in atherosclerosis.
    5. (2002). Innate and acquired immunity in atherogenesis.
    6. (1996). Mouse models of atherosclerosis.
    7. (2002). The unconventional lifestyle of NKT cells.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.